Enzyme immunoassay system for serological diagnosis of hemorrhagic fever with renal syndrome based on inactivated purified Puumala virus (Hantaviridae: Orthohantavirus)

Autor: Alexander P. Ivanov, Tamara K. Dzagurova, Svetlana S. Kurashova, Rostislav D. Teodorovich, Tatyana D. Klebleeva, Eugeny A. Tkachenko

Publikováno v: Вопросы вирусологии, Vol 69, Iss 3, Pp 285-289 (2024)

Introduction. Hemorrhagic fever with renal syndrome (HFRS) is the most common zoonotic human viral disease in the Russian Federation. More than 98% of the HFRS cases are caused by Puumala orthohantavirus (PUU). Effective serological tests are require

Externí odkaz: https://doaj.org/article/a576f2ee1e9344eabdd44632429d12c4

Pre-Clinical Studies of Inactivated Polyvalent HFRS Vaccine

Autor: Tamara K. Dzagurova, Alexandra A. Siniugina, Aidar A. Ishmukhametov, Maria S. Egorova, Svetlana S. Kurashova, Maria V. Balovneva, Andrey A. Deviatkin, Petr E. Tkachenko, Oksana A. Leonovich, Evgeny A. Tkachenko

Publikováno v: Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)

Hemorrhagic fever with renal syndrome (HFRS) is the most common natural focal disease in the Russian Federation with about 6–12 thousand cases annually. 97.7% of all HFRS cases in Russia are caused by the Puumala virus, 1.5%—by the Hantaan, Amur,

Externí odkaz: https://doaj.org/article/6e1230b7a81b4a6297eecef7fab51db0

Effect of Virus-Inactivating Agents on the Immunogenicity of Hantavirus Vaccines against Hemorrhagic Fever with Renal Syndrome

Autor: M. S. Egorova, Svetlana S. Kurashova, Evgeniy A. Tkachenko, Dzagurova Tk, M. V. Balovneva, Aidar Ishmukhametov

Publikováno v: Applied Biochemistry and Microbiology. 56:940-947

Hemorrhagic fever with renal syndrome (HFRS) is an acute zoonotic disease caused by the orthohantaviruses Puumala, Dobrava-Belgrad (four genotypes), Hantaan (genotype Amur), and Seoul. In the Russian Federation, HFRS occupies the leading place among

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::78d47c4ac210bf7e624b4e2ff2fea647
https://doi.org/10.1134/s0003683820090045

[Real-time PCR assay development for the control of vaccine against hemorrhagic fever with renal syndrome]

Autor: Andrei A. Deviatkin, A.A. Ishmukhametov, Svetlana S. Kurashova, A V Belyakova, M. V. Balovneva, Marina V. Safonova, Evgeniy A. Tkachenko, Yu. Kh. Khapchaev, S V Ozherelkov, Dzagurova Tk, M. S. Egorova, A S Balkina

Publikováno v: Voprosy virusologii. 66(1)

Introduction. Hemorrhagic fever with renal syndrome (HFRS) holds a leading place among natural focal human diseases in Russian Federation. There is no etiotropic therapy for the disease now. The vaccine prophylaxis is the most effective method to con

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a3fff1ed61318614a3268863cbd6f51
https://pubmed.ncbi.nlm.nih.gov/33683067

The Specificity of Epizootic and Epidemiological Processes in Natural Foci of Hemorrhagic Fever with Renal Syndrome and Tick-Borne Encephalitis in Russia, as the Basis for the Prospects of Creating a Combined Vaccine for the Prevention of These Infections.

Autor: Tkachenko E; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia., Balkina A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia., Trankvilevsky D; Federal Center of Hygiene and Epidemiology, Moscow 117105, Russia., Kolyasnikova N; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia., Teodorovich R; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia., Vorovich M; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia.; Department of Internal Disease Propaedeutics, Sechenov First Moscow State Medical University, Moscow 119991, Russia., Popova Y; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia., Kurashova S; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia., Egorova M; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia., Belyakova A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia., Tkachenko P; Department of Internal Disease Propaedeutics, Sechenov First Moscow State Medical University, Moscow 119991, Russia., Ishmukhametov A; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia.; Department of Internal Disease Propaedeutics, Sechenov First Moscow State Medical University, Moscow 119991, Russia., Dzagurova T; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Institute of Poliomyelitis, Moscow 108819, Russia.

Publikováno v: Viruses [Viruses] 2024 Aug 13; Vol. 16 (8). Date of Electronic Publication: 2024 Aug 13.